Company intelligence / Profile preview

Bios Health Group

Atlanta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Bios Health Group offers a suite of solutions—investment support (BioInvest), clinical development optimization (Innovate Bio), CRO selection (CRO Select), and commercial strategy (LaunchMax). Their Bios Innovation Circle connects industry mentors, investors, and partners to accelerate progress for biotech/life science companies. The company does not run clinical trials, but supports companies from concept to commercialization with funding ($1M–$100M typical range), partner network, and strategic guidance.

Industry: Investors

Partnerships

Life science companiesInvestorsCROsPharmaceutical companies

Beyond the preview

Go deeper on Bios Health Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bios Health Group.

Explore the full profile